None listed
Conditions
Interventions
Intervention1: Cholecalciferol (vitamin D3) oral: 60,000 units of oral vitamin D3 given under observation one dose, followed after 3 months by 120,000 units one dose.
Control Intervention1: nil: no co
Sponsors
Self
Eligibility
Inclusion criteria
Inclusion criteria: Willing to participate
Exclusion criteria
Exclusion criteria: Liver, kidney disease, or taken anticonvulsant or antitubercular drugs or vitamin D containing preparation in last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of subjects with seum 25OHD 20 ng/ml over 3 months after dose of vitamin DTimepoint: 1 and 2 and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in serum 25OHD over 3 monthsTimepoint: 1 and 2 and 3 months | — |
Countries
India
Contacts
Public ContactVijayalakshmi Bhatia
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Outcome results
None listed